ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Treatment Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38V5429
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Tumor Treatment Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tumor Treatment Drug Market Research Report 2025

Code: QYRE-Auto-38V5429
Report
July 2025
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Celgene
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Merck
Astrazeneca plc
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Sanofi
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences

Tumor Treatment Drug Market Size

The global market for Tumor Treatment Drug was valued at US$ 1838 million in the year 2024 and is projected to reach a revised size of US$ 2748 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Tumor Treatment Drug Market

Tumor Treatment Drug Market

Tumor is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tumor Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Treatment Drug.
The Tumor Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Treatment Drug Market Report

Report Metric Details
Report Name Tumor Treatment Drug Market
Accounted market size in year US$ 1838 million
Forecasted market size in 2031 US$ 2748 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Tumor Treatment Drug Market growing?

Ans: The Tumor Treatment Drug Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Tumor Treatment Drug Market size in 2031?

Ans: The Tumor Treatment Drug Market size in 2031 will be US$ 2748 million.

Who are the main players in the Tumor Treatment Drug Market report?

Ans: The main players in the Tumor Treatment Drug Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

What are the Application segmentation covered in the Tumor Treatment Drug Market report?

Ans: The Applications covered in the Tumor Treatment Drug Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Others

What are the Type segmentation covered in the Tumor Treatment Drug Market report?

Ans: The Types covered in the Tumor Treatment Drug Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

Recommended Reports

Cancer Therapies

Organ-specific Cancer

Treatment Methods

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tumor Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Treatment Drug Market Perspective (2020-2031)
2.2 Global Tumor Treatment Drug Growth Trends by Region
2.2.1 Global Tumor Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Tumor Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Tumor Treatment Drug Market Dynamics
2.3.1 Tumor Treatment Drug Industry Trends
2.3.2 Tumor Treatment Drug Market Drivers
2.3.3 Tumor Treatment Drug Market Challenges
2.3.4 Tumor Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Treatment Drug Players by Revenue
3.1.1 Global Top Tumor Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Tumor Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Treatment Drug Revenue
3.4 Global Tumor Treatment Drug Market Concentration Ratio
3.4.1 Global Tumor Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Treatment Drug Revenue in 2024
3.5 Global Key Players of Tumor Treatment Drug Head office and Area Served
3.6 Global Key Players of Tumor Treatment Drug, Product and Application
3.7 Global Key Players of Tumor Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Treatment Drug Breakdown Data by Type
4.1 Global Tumor Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Tumor Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Tumor Treatment Drug Breakdown Data by Application
5.1 Global Tumor Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Tumor Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Treatment Drug Market Size (2020-2031)
6.2 North America Tumor Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Treatment Drug Market Size by Country (2020-2025)
6.4 North America Tumor Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Treatment Drug Market Size (2020-2031)
7.2 Europe Tumor Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Tumor Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Tumor Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Treatment Drug Market Size (2020-2031)
9.2 Latin America Tumor Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Tumor Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Tumor Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Tumor Treatment Drug Introduction
11.1.4 Roche Revenue in Tumor Treatment Drug Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Tumor Treatment Drug Introduction
11.2.4 Celgene Revenue in Tumor Treatment Drug Business (2020-2025)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Tumor Treatment Drug Introduction
11.3.4 Novartis Revenue in Tumor Treatment Drug Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Tumor Treatment Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Tumor Treatment Drug Introduction
11.5.4 Johnson & Johnson Revenue in Tumor Treatment Drug Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Tumor Treatment Drug Introduction
11.6.4 Merck & Co. Revenue in Tumor Treatment Drug Business (2020-2025)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Tumor Treatment Drug Introduction
11.7.4 AstraZeneca Revenue in Tumor Treatment Drug Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Tumor Treatment Drug Introduction
11.8.4 Pfizer Revenue in Tumor Treatment Drug Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Tumor Treatment Drug Introduction
11.9.4 Amgen Revenue in Tumor Treatment Drug Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Tumor Treatment Drug Introduction
11.10.4 Eli Lilly Revenue in Tumor Treatment Drug Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Tumor Treatment Drug Introduction
11.11.4 AbbVie Revenue in Tumor Treatment Drug Business (2020-2025)
11.11.5 AbbVie Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Tumor Treatment Drug Introduction
11.12.4 Takeda Revenue in Tumor Treatment Drug Business (2020-2025)
11.12.5 Takeda Recent Development
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Tumor Treatment Drug Introduction
11.13.4 Astellas Revenue in Tumor Treatment Drug Business (2020-2025)
11.13.5 Astellas Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Tumor Treatment Drug Introduction
11.14.4 Ipsen Revenue in Tumor Treatment Drug Business (2020-2025)
11.14.5 Ipsen Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Tumor Treatment Drug Introduction
11.15.4 Sanofi Revenue in Tumor Treatment Drug Business (2020-2025)
11.15.5 Sanofi Recent Development
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Tumor Treatment Drug Introduction
11.16.4 Bayer Revenue in Tumor Treatment Drug Business (2020-2025)
11.16.5 Bayer Recent Development
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Tumor Treatment Drug Introduction
11.17.4 Biogen Idec Revenue in Tumor Treatment Drug Business (2020-2025)
11.17.5 Biogen Idec Recent Development
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Tumor Treatment Drug Introduction
11.18.4 Teva Revenue in Tumor Treatment Drug Business (2020-2025)
11.18.5 Teva Recent Development
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Tumor Treatment Drug Introduction
11.19.4 Otsuka Revenue in Tumor Treatment Drug Business (2020-2025)
11.19.5 Otsuka Recent Development
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Tumor Treatment Drug Introduction
11.20.4 Eisai Revenue in Tumor Treatment Drug Business (2020-2025)
11.20.5 Eisai Recent Development
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Tumor Treatment Drug Introduction
11.21.4 Merck KGaA Revenue in Tumor Treatment Drug Business (2020-2025)
11.21.5 Merck KGaA Recent Development
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Tumor Treatment Drug Introduction
11.22.4 Gilead Sciences Revenue in Tumor Treatment Drug Business (2020-2025)
11.22.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Celgene
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Merck
Astrazeneca plc
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Sanofi
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences
List of Tables
 Table 1. Global Tumor Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemotherapy
 Table 3. Key Players of Targeted Therapy
 Table 4. Key Players of Immunotherapy (Biologic Therapy)
 Table 5. Key Players of Hormonal Therapy
 Table 6. Key Players of Others
 Table 7. Global Tumor Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Tumor Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Tumor Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Tumor Treatment Drug Market Share by Region (2020-2025)
 Table 11. Global Tumor Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Tumor Treatment Drug Market Share by Region (2026-2031)
 Table 13. Tumor Treatment Drug Market Trends
 Table 14. Tumor Treatment Drug Market Drivers
 Table 15. Tumor Treatment Drug Market Challenges
 Table 16. Tumor Treatment Drug Market Restraints
 Table 17. Global Tumor Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Tumor Treatment Drug Market Share by Players (2020-2025)
 Table 19. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2024)
 Table 20. Ranking of Global Top Tumor Treatment Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Tumor Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Tumor Treatment Drug, Headquarters and Area Served
 Table 23. Global Key Players of Tumor Treatment Drug, Product and Application
 Table 24. Global Key Players of Tumor Treatment Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Tumor Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Tumor Treatment Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global Tumor Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Tumor Treatment Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global Tumor Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Tumor Treatment Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global Tumor Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Tumor Treatment Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Tumor Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Tumor Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Tumor Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Tumor Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Tumor Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Tumor Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Tumor Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Tumor Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Tumor Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Tumor Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Tumor Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Roche Company Details
 Table 50. Roche Business Overview
 Table 51. Roche Tumor Treatment Drug Product
 Table 52. Roche Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 53. Roche Recent Development
 Table 54. Celgene Company Details
 Table 55. Celgene Business Overview
 Table 56. Celgene Tumor Treatment Drug Product
 Table 57. Celgene Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 58. Celgene Recent Development
 Table 59. Novartis Company Details
 Table 60. Novartis Business Overview
 Table 61. Novartis Tumor Treatment Drug Product
 Table 62. Novartis Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 63. Novartis Recent Development
 Table 64. Bristol-Myers Squibb Company Details
 Table 65. Bristol-Myers Squibb Business Overview
 Table 66. Bristol-Myers Squibb Tumor Treatment Drug Product
 Table 67. Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 68. Bristol-Myers Squibb Recent Development
 Table 69. Johnson & Johnson Company Details
 Table 70. Johnson & Johnson Business Overview
 Table 71. Johnson & Johnson Tumor Treatment Drug Product
 Table 72. Johnson & Johnson Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 73. Johnson & Johnson Recent Development
 Table 74. Merck & Co. Company Details
 Table 75. Merck & Co. Business Overview
 Table 76. Merck & Co. Tumor Treatment Drug Product
 Table 77. Merck & Co. Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 78. Merck & Co. Recent Development
 Table 79. AstraZeneca Company Details
 Table 80. AstraZeneca Business Overview
 Table 81. AstraZeneca Tumor Treatment Drug Product
 Table 82. AstraZeneca Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 83. AstraZeneca Recent Development
 Table 84. Pfizer Company Details
 Table 85. Pfizer Business Overview
 Table 86. Pfizer Tumor Treatment Drug Product
 Table 87. Pfizer Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 88. Pfizer Recent Development
 Table 89. Amgen Company Details
 Table 90. Amgen Business Overview
 Table 91. Amgen Tumor Treatment Drug Product
 Table 92. Amgen Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 93. Amgen Recent Development
 Table 94. Eli Lilly Company Details
 Table 95. Eli Lilly Business Overview
 Table 96. Eli Lilly Tumor Treatment Drug Product
 Table 97. Eli Lilly Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 98. Eli Lilly Recent Development
 Table 99. AbbVie Company Details
 Table 100. AbbVie Business Overview
 Table 101. AbbVie Tumor Treatment Drug Product
 Table 102. AbbVie Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 103. AbbVie Recent Development
 Table 104. Takeda Company Details
 Table 105. Takeda Business Overview
 Table 106. Takeda Tumor Treatment Drug Product
 Table 107. Takeda Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 108. Takeda Recent Development
 Table 109. Astellas Company Details
 Table 110. Astellas Business Overview
 Table 111. Astellas Tumor Treatment Drug Product
 Table 112. Astellas Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 113. Astellas Recent Development
 Table 114. Ipsen Company Details
 Table 115. Ipsen Business Overview
 Table 116. Ipsen Tumor Treatment Drug Product
 Table 117. Ipsen Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 118. Ipsen Recent Development
 Table 119. Sanofi Company Details
 Table 120. Sanofi Business Overview
 Table 121. Sanofi Tumor Treatment Drug Product
 Table 122. Sanofi Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 123. Sanofi Recent Development
 Table 124. Bayer Company Details
 Table 125. Bayer Business Overview
 Table 126. Bayer Tumor Treatment Drug Product
 Table 127. Bayer Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 128. Bayer Recent Development
 Table 129. Biogen Idec Company Details
 Table 130. Biogen Idec Business Overview
 Table 131. Biogen Idec Tumor Treatment Drug Product
 Table 132. Biogen Idec Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 133. Biogen Idec Recent Development
 Table 134. Teva Company Details
 Table 135. Teva Business Overview
 Table 136. Teva Tumor Treatment Drug Product
 Table 137. Teva Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 138. Teva Recent Development
 Table 139. Otsuka Company Details
 Table 140. Otsuka Business Overview
 Table 141. Otsuka Tumor Treatment Drug Product
 Table 142. Otsuka Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 143. Otsuka Recent Development
 Table 144. Eisai Company Details
 Table 145. Eisai Business Overview
 Table 146. Eisai Tumor Treatment Drug Product
 Table 147. Eisai Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 148. Eisai Recent Development
 Table 149. Merck KGaA Company Details
 Table 150. Merck KGaA Business Overview
 Table 151. Merck KGaA Tumor Treatment Drug Product
 Table 152. Merck KGaA Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 153. Merck KGaA Recent Development
 Table 154. Gilead Sciences Company Details
 Table 155. Gilead Sciences Business Overview
 Table 156. Gilead Sciences Tumor Treatment Drug Product
 Table 157. Gilead Sciences Revenue in Tumor Treatment Drug Business (2020-2025) & (US$ Million)
 Table 158. Gilead Sciences Recent Development
 Table 159. Research Programs/Design for This Report
 Table 160. Key Data Information from Secondary Sources
 Table 161. Key Data Information from Primary Sources
 Table 162. Authors List of This Report


List of Figures
 Figure 1. Tumor Treatment Drug Picture
 Figure 2. Global Tumor Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor Treatment Drug Market Share by Type: 2024 VS 2031
 Figure 4. Chemotherapy Features
 Figure 5. Targeted Therapy Features
 Figure 6. Immunotherapy (Biologic Therapy) Features
 Figure 7. Hormonal Therapy Features
 Figure 8. Others Features
 Figure 9. Global Tumor Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Tumor Treatment Drug Market Share by Application: 2024 VS 2031
 Figure 11. Blood Cancer Case Studies
 Figure 12. Breast Cancer Case Studies
 Figure 13. Gastrointestinal Cancer Case Studies
 Figure 14. Prostate Cancer Case Studies
 Figure 15. Respiratory/Lung Cancer Case Studies
 Figure 16. Others Case Studies
 Figure 17. Tumor Treatment Drug Report Years Considered
 Figure 18. Global Tumor Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Tumor Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Tumor Treatment Drug Market Share by Region: 2024 VS 2031
 Figure 21. Global Tumor Treatment Drug Market Share by Players in 2024
 Figure 22. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Tumor Treatment Drug Revenue in 2024
 Figure 24. North America Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Tumor Treatment Drug Market Share by Country (2020-2031)
 Figure 26. United States Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Tumor Treatment Drug Market Share by Country (2020-2031)
 Figure 30. Germany Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Tumor Treatment Drug Market Share by Region (2020-2031)
 Figure 38. China Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Tumor Treatment Drug Market Share by Country (2020-2031)
 Figure 46. Mexico Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Tumor Treatment Drug Market Share by Country (2020-2031)
 Figure 50. Turkey Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Tumor Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Roche Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 54. Celgene Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 55. Novartis Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 57. Johnson & Johnson Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 58. Merck & Co. Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 59. AstraZeneca Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 61. Amgen Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 62. Eli Lilly Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 63. AbbVie Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 64. Takeda Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 65. Astellas Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 66. Ipsen Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 67. Sanofi Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 68. Bayer Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 69. Biogen Idec Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 70. Teva Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 71. Otsuka Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 72. Eisai Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 73. Merck KGaA Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 74. Gilead Sciences Revenue Growth Rate in Tumor Treatment Drug Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Oncology Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Oncology Market Insights Forecast to 2030
Cancer Treatment Drugs Market
Global Oncology Drugs Market Insights Forecast to 2030
Oncology Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Therapeutic Drug Market Research Report 2024
Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030
Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Brain Cancer Targeted Drug Market Research Report 2025
Sarcoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Targeted Therapy for Brain Cancer Market Research Report 2025
Global Breast Cancer Targeted Drug Market Research Report 2025
Global Breast Cancer Drugs Market Insights Forecast to 2030
Global Targeted Therapy for Breast Cancer Market Research Report 2025
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Brain Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti tumor Drug Market Research Report 2025
Global Brain Tumor Therapeutics Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions